AGIOS PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2013 to Q3 2024.
  • Agios Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 56.9M shares, a 2.04% increase year-over-year.
  • Agios Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 55.7M shares, a 1.57% increase from 2022.
  • Agios Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 54.8M shares, a 9.36% decline from 2021.
  • Agios Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 60.4M shares, a 12.4% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 56.9M +1.14M +2.04% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 56.8M +1.2M +2.16% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 56.4M +1.12M +2.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 55.7M +862K +1.57% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 55.8M +959K +1.75% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 55.6M +805K +1.47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 55.3M +710K +1.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 54.8M -5.66M -9.36% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 54.8M -2.2M -3.86% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 54.8M -6.27M -10.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 54.6M -15M -21.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 60.4M -8.55M -12.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 57M -12.1M -17.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 61.1M -7.89M -11.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 69.5M +935K +1.36% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 69M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 69.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 69M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 68.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q3 2015 37.5M +3.01M +8.73% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q3 2014 34.5M +11.8M +51.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q3 2013 22.7M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.